Search results
Hepatitis C Treatment Costs: What to Expect
Verywell Health via Yahoo News· 2 years agoHepatitis C is a liver infection caused by the hepatitis C virus (HCV). Prior to the introduction of a new class of drugs called direct-acting antivirals...
Hepatitis on track to overtake TB as world’s biggest infectious killer
The Telegraph via Yahoo News· 1 month agoThe hepatitis B and C viruses are the most severe strains and, together, are the primary causes of...
What Is Hepatitis C (HCV)?
Verywell Health via Yahoo News· 1 year agoHepatitis C is an infection caused by the hepatitis C virus (HCV) that is mainly transmitted through shared needles. Hepatitis C causes few (if any)...
11 Best Pharma Stocks To Buy Now
Insider Monkey via Yahoo Finance· 7 months agoIn this article, we discuss the 12 best pharma stocks to buy now. You can skip our detailed analysis of the pharmaceutical sector and its outlook this...
3 Top Pharma Stocks to Buy Now: February 2024
InvestorPlace via Yahoo Finance· 4 months agoLooking for pharma stocks to buy in February 2024? The pharmaceutical industry has always drawn a big crowd of investors. It has a veritable laundry list...
There's A Real Chance To Stop This Miserable, Fatal Infection
HuffPost via Yahoo News· 6 months agoDying from hepatitis C is a notoriously miserable way to go. The virus attacks your liver ― in many...
Why NuCana Shares Are Rising Today?
Benzinga via Yahoo Finance· 2 years agoRegional Court of Dusseldorf has ruled in favor of NuCana plc (NASDAQ: NCNA), stating that Gilead Sciences Ireland UC and Gilead Sciences GmbH infringed...
These 3 Stocks Are Rallying While the Rest of the Market Plunges
Motley Fool· 1 year agoThe broad market may be up a bit for the past few weeks. The bigger trend, however, remains bearish....
Gilead (GILD) Reports Q4 Earnings: What Key Metrics Have to Say
Zacks via Yahoo Finance· 1 year agoAlthough the revenue and EPS for Gilead (GILD) give a sense of how its business performed in the...
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 weeks agoArbutus Biopharma Corporation (NASDAQ:ABUS) Q1 2024 Earnings Call Transcript May 2, 2024 Arbutus...
